Login / Signup

Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH).

Fernando WarleyMariano BerroSilvina PalmerMartin CastroGonzalo FeriniMilagros Lopez OrozcoVictoria OteroJorge ArbelbideCecilia FoncubertaSebastián YantornoAna Lisa Basquiera
Published in: Leukemia & lymphoma (2022)
Keyphrases
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma
  • multiple myeloma
  • hodgkin lymphoma
  • cell therapy
  • double blind
  • clinical trial
  • mesenchymal stem cells